Publications

Shining a Light on Barrier Function.

Friedrich M. and Travis S., (2022), Gastroenterology

Is Crohn's Disease a Rightly Used Eponym?

Van Hootegem P. and Travis S., (2020), Journal of Crohn's & colitis, 14, 867 - 871

The impact of intestinal transplantation on quality of life

Ambrose T. et al, (2020), Clinical Nutrition, 39, 1958 - 1967

Management of pouch-vaginal fistulas - experience from our institution.

Sivathondan PC. et al, (2020), Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 22, 439 - 444

Temporary faecal diversion in ileocolic resection for Crohn’s disease: is there an impact on long‐term surgical recurrence?

Bolckmans R. et al, (2020), Colorectal Disease, 22, 430 - 438

Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.

Panaccione R. et al, (2020), Gut, 69, 658 - 664

Does Smoking Cessation Reduce Surgical Recurrence After Primary Ileocolic Resection for Crohn's Disease?

Bolckmans R. et al, (2020), Diseases of the colon and rectum, 63, 200 - 206

Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2.

Mukhopadhyay S. et al, (2020), The Journal of experimental medicine, 217

The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing Data.

Cohen RD. et al, (2020), Journal of Crohn's & colitis, 14, 192 - 204

IM-UNITI at Three Years: Stellar Stelara® or Stardust? The Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.

Travis S., (2020), Journal of Crohn's & colitis, 14, 1 - 3

Remission of Inflammatory Bowel Disease in Glucose-6-Phosphatase 3 Deficiency by Allogeneic Haematopoietic Stem Cell Transplantation

Bolton C. et al, (2020), Journal of Crohn's and Colitis, 14, 142 - 147

Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data.

Card T. et al, (2020), Alimentary pharmacology & therapeutics, 51, 149 - 157

Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study

Snowden JA. et al, (2019), BMC Gastroenterology, 19

TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions

Leng T. et al, (2019), Cell Reports, 28, 3077 - 3091.e5

Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy study.

Taylor SA. et al, (2019), Health technology assessment (Winchester, England), 23, 1 - 162

Systems-level analysis of monocyte responses in inflammatory bowel disease identifies IL-10 and IL-1 cytokine networks that regulate IL-23

Aschenbrenner D. et al, (2019)

Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis

Walsh A. et al, (2019), Intestinal Research, 17, 365 - 374

Authors’ reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn’s Disease Behavior, Fecal Calprotectin and Quality of Life

Bryant RV. et al, (2019), Inflammatory Bowel Diseases, 25, e62 - e63

Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis—a Prospective Analysis

Walsh A. et al, (2019), Journal of Crohn's and Colitis, 13, 424 - 430

Visceral Adipose Tissue Is Associated With Stricturing Crohn’s Disease Behavior, Fecal Calprotectin, and Quality of Life

Bryant RV. et al, (2019), Inflammatory Bowel Diseases, 25, 592 - 600

Cookies on this website

Publications